Publications
2025
Barriers and Solutions to Optimal Food Allergy Prevention, Diagnostic, and Management Strategies. J Allergy Clin Immunol Pract. 2025 Apr 26;. doi: 10.1016/j.jaip.2025.04.030. [Epub ahead of print] PubMed PMID: 40294846.
Humphrey JR, Guo R, Yue X, Keet CA, Virkud YV, Bird JA, Burks AW, Kim EH, Smeekens JM, Kulis MD. Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy. J Allergy Clin Immunol. 2025 Apr 15:S0091-6749(25)00417-8. doi: 10.1016/j.jaci.2025.04.010. Epub ahead of print. PMID: 40245952.
Keet CA, Burks AW. To Eat or Not to Eat – Oral Immunotherapy for High-Threshold Peanut Allergy. NEJM Evid. 2025 Mar;4(3):EVIDe2400448. doi: 10.1056/EVIDe2400448. Epub 2025 Feb 25. PMID: 39998307.
Deficiency of H3K27 histone demethylase UTX in T cells blunts allergic sensitization and anaphylaxis to peanut. Immunohorizons. 2025 Feb 18;9(4). doi: 10.1093/immhor/vlaf008. PubMed PMID: 40065718; PubMed Central PMCID: PMC11893976.
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2025 Jan;155(1):62-69.e1. doi: 10.1016/j.jaci.2024.09.031. Epub 2024 Nov 22. PubMed PMID: 39580718
2024
Immunomodulatory metabolites in IgE-mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling Nov 2024 [Virkud]
The availability of allergen-friendly food for college students experiencing food insecurity: Exploring current campus practices Nov 2024 [Virkud]
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study Nov 2024 [Keet, Kim]
Community and academic allergists’ perspectives on integrating biologics into food allergy care Oct 2024 [Fisher, Kim]
A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice Aug 2024 [Smeekens, Burks, Kulis]
Targeting inhibitory Siglec-3 to suppress IgE-mediated human basophil degranulation Aug 2024 [Commins, Kulis]
Indoor allergen exposure and its association to upper respiratory infections and pulmonary outcomes among children with asthma Aug 2024 [Keet]
Rates of New Peanut Allergy and Discontinuation Following Introduction in High-Risk Infants Mar 2024 [Keet]
Omalizumab for the Treatment of Multiple Food Allergies Feb 2024 [Kim, Keet, Kulis]
Different airborne particulates trigger distinct immune pathways leading to peanut allergy in a mouse model Feb 2024 [Immormimo, Smeekens, Mathai, Kulis, Moran]
Management of Food Allergies and Food-Related Anaphylaxis Feb 2024 [Virkud, Iweala]
A Mouse Model of Shrimp Allergy with Cross-Reactivity to Crab and Lobster 2024 [Smeekens, Kesselring, Kulis]
2023
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut allergic children Jun 2023 [Kim, Keet, Virkud, Penumarti, Smeekens, Guo, Yue, Kulis, Burks]
The SunBEAm birth cohort: Protocol design Aug 2023 [Keet, Kim]
Environmental Exposure to Foods as a Risk Factor for Food Allergy Aug 2023 [Turner, Smeekens]
A single priming event prevents oral tolerance to peanut Sep 2023 [Smeekens, Kesselring, Turner, Kulis, Moran]
Desensitization and remission after peanut sublingual immunotherapy in 1-to-4-year-old peanut-allergic children: A randomized, placebo-controlled trial Oct 2023 [Kim, Keet, Virkud, Herlihy, Smeekens, Guo, Yue, Penumarti, Kulis, Burks]
Frequency and predictors of multisystem reactions to peanut in infant oral food challenges Oct 2023 [Keet]